Top 10 Dividend Stocks

3. AbbVie Inc. (NYSE:ABBV)

Dividend Yield as of July 25: 3.80%

An American pharmaceutical company, AbbVie Inc. (NYSE:ABBV) pays a quarterly dividend of $1.41 per share. The company was a subsidiary of Abbott Laboratories and separated from it in 2013. It has been raising its dividends consecutively for the past 50 years. As of July 25, the stock’s dividend yield came in at 3.80%.

In July, Morgan Stanly raised its price target on AbbVie Inc. (NYSE:ABBV) to $191 with an Overweight rating on the shares, ahead of the company’s Q2 earnings.

As per Insider Monkey’s database, 76 hedge funds were bullish on AbbVie Inc. (NYSE:ABBV) in Q1, down from 82 in the previous quarter. These stakes are valued at over $3.6 billion. Among these hedge funds, Arrowstreet Capital was the company’s largest stakeholder in Q1.

Carillon Tower Advisers mentioned AbbVie Inc. (NYSE:ABBV) in its Q1 2022 investor letter. Here is what the firm has to say:

“Stock selection contributed the most while sector allocation was also positive. An underweight to communication services and an overweight to energy helped performance, while an underweight to consumer staples and an overweight to materials detracted. Stock selection was strong within healthcare and materials but was weak within information technology and industrials. AbbVie (NYSE:ABBV) is a research-based biopharmaceutical company. Shares gained after the company reported earnings that missed revenue but beat earnings-per-share estimates. Discussion around the report was mixed but skewed positive.”